Stockreport

ImmunoGen sells Kadcyla royalties for $65M [Seeking Alpha]

ImmunoGen, Inc.  (IMGN) 
Last immunogen, inc. earnings: 5/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.immunogen.com/investor-relations
PDF ImmunoGen sells Kadcyla royalties for $65MImmunoGen (NASDAQ:IMGN) hassold its Kadcyla (ado-trastuzumab) royalty stream to a Canadian pension plan called OMERS for $65M. [Read more]